The Effect of Whole Body Vibration on Walking Parameters in Children With Cerebral Palsy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cerebral Palsy
- Sponsor
- Kutahya Health Sciences University
- Enrollment
- 13
- Locations
- 1
- Primary Endpoint
- Spatiotemporal parameters of gait will be evaluated with the Zebris™ FDM-2 gait analysis platform.
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Some positive effects of whole body vibration applications in reducing spasticity, improving walking ability, and increasing walking speed have been reported in children with CP, but the evidence is not strong enough. Therefore, this study was planned to evaluate the effect of whole body vibration treatment on spasticity, gait, balance, and motor performance in children with spastic CP. This study hypothesis that whole body vibration provides an additive improvement on spasticity, balance, gait and motor performance.
Detailed Description
Participants will be evaluate at baseline, after the conventional physiotherapy program, and after whole body vibration training program. During this period, the participants who were recruited whole body vibration training program, whole body vibration will be applied in addition to conventional physiotherapy sessions comprised 45 min, 2 days a week, during 8 week.
Investigators
Eda Ozge OKUR
Assistant Professor
Kutahya Health Sciences University
Eligibility Criteria
Inclusion Criteria
- •Children diagnosed with spastic diplegic CP in GMFCS levels I and II, CFCS level I and MACS levels I and II
- •Aged 6-17 years
- •Ability to cooperate with the evaluations
- •Walking independently with or without an orthosis (without any support)
Exclusion Criteria
- •Having a recent injury affecting the lower extremities
- •Having undergone any surgery or Botulinuim Toxin application within the last six months
- •Having severe cardiopulmonary or systemic problems
- •Having uncontrolled seizures, visual or hearing problems preventing the evaluations
Outcomes
Primary Outcomes
Spatiotemporal parameters of gait will be evaluated with the Zebris™ FDM-2 gait analysis platform.
Time Frame: Change from baseline velocity at 2 months.
Gait analysis will be performed without any shoes and assistive devices. Walking evaluation on the gait platform will be limited to 1 minute. Obtained data about velocity will be collected as meters/seconds from the entire 1-minute walk will use for analysis.
Secondary Outcomes
- The Pediatric Balance Scale will be used to measure functional balance of the participants.(Change from baseline score at 2 months.)